Literature DB >> 26492844

Safety and Effectiveness of Early Colonoscopy in Management of Acute Lower Gastrointestinal Bleeding on the Basis of Propensity Score Matching Analysis.

Naoyoshi Nagata1, Ryota Niikura2, Toshiyuki Sakurai2, Takuro Shimbo3, Tomonori Aoki2, Shiori Moriyasu2, Katsunori Sekine2, Hidetaka Okubo2, Koh Imbe2, Kazuhiro Watanabe2, Chizu Yokoi2, Mikio Yanase2, Junichi Akiyama2, Naomi Uemura4.   

Abstract

BACKGROUND & AIMS: We investigated the safety and effectiveness of early colonoscopy (performed within 24 hours of hospital admission) for acute lower gastrointestinal bleeding (LGIB) vs elective colonoscopy (performed 24 hours after admission).
METHODS: We conducted a retrospective study by using a database of endoscopies performed at the National Center for Global Health and Medicine in Tokyo, Japan from January 2009 through December 2014. We analyzed data from 538 patients emergently hospitalized for acute LGIB. We used propensity score matching to adjust for differences between patients who underwent early colonoscopy vs elective colonoscopy. Outcomes included rates of adverse events during bowel preparation and colonoscopy procedures, stigmata of recent hemorrhage, endoscopic therapy, blood transfusion requirement, 30-day rebleeding and mortality, and length of hospital stay.
RESULTS: We selected 163 pairs of patients for analysis on the basis of propensity matching. We observed no significant differences between the early and elective colonoscopy groups in bowel preparation-related rates of adverse events (1.8% vs 1.2%, P = .652), colonoscopy-related rates of adverse events (none in either group), blood transfusion requirement (27.6% vs 27.6%, P = 1.000), or mortality (1.2% vs 0, P = .156). The early colonoscopy group had higher rates than the elective group for stigmata of recent hemorrhage (26.4% vs 9.2%, P < .001) and endoscopic therapy (25.8% vs 8.6%, P < .001), including clipping (17.8% vs 4.9%, P < .001), band ligation (6.1% vs 1.8%, P = .048), and rebleeding (13.5% vs 7.4%, P = .070). Patients in the early colonoscopy group stayed in the hospital for a shorter mean time (10 days) than patients in the elective colonoscopy group (13 days) (P < .001).
CONCLUSIONS: Early colonoscopy for patients with acute LGIB is safe, allows for endoscopic therapy because it identifies the bleeding source, and reduces hospital stay. However, compared with elective colonoscopy, early colonoscopy does not reduce mortality and may increase the risk for rebleeding.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colonoscopy Timing; Comparative Analysis; Diverticular Bleeding; Lower Gastrointestinal Hemorrhage; Urgent Colonoscopy

Mesh:

Year:  2015        PMID: 26492844     DOI: 10.1016/j.cgh.2015.10.011

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  22 in total

1.  [Value of urgent colonoscopy in diagnosis of severe acute lower gastrointestinal bleeding in patients with different bowel cleanliness].

Authors:  Jing Li; Jin Tang; Ye Chen; Fa-Chao Zhi; Si-de Liu; Mei-Rong He
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-04-20

2.  Red blood cell transfusions for emergency department patients with gastrointestinal bleeding within an integrated health system.

Authors:  Dustin G Mark; Jie Huang; Colleen Plimier; Mary E Reed; Gabriel J Escobar; David R Vinson; Nareg H Roubinian
Journal:  Am J Emerg Med       Date:  2019-06-10       Impact factor: 2.469

3.  Has an Observational Study of Early vs Elective Colonoscopy for Acute Lower Gastrointestinal Hemorrhage Answered Questions That Clinical Trials Could Not?

Authors:  Lisa L Strate; Thomas F Imperiale
Journal:  Clin Gastroenterol Hepatol       Date:  2015-12-24       Impact factor: 11.382

Review 4.  Current Nonoperative Therapeutic Interventions for Lower Gastrointestinal Hemorrhage.

Authors:  Anna Serur; Rebecca Rhee; Joshua Ramjist
Journal:  Clin Colon Rectal Surg       Date:  2019-11-11

5.  Early Colonoscopy Does Not Affect 30-Day Readmission After Lower GI Bleeding: Insights from a Nationwide Analysis.

Authors:  Sachit Sharma; Deema Sallout; Ashu Acharya; Douglas G Adler
Journal:  Dig Dis Sci       Date:  2021-09-14       Impact factor: 3.487

6.  Current state of practice for colonic diverticular bleeding in 37 hospitals in Japan: A multicenter questionnaire study.

Authors:  Ryota Niikura; Naoyoshi Nagata; Hisashi Doyama; Ryosuke Ota; Naoki Ishii; Katsuhiro Mabe; Tsutomu Nishida; Takuto Hikichi; Kazuki Sumiyama; Jun Nishikawa; Toshio Uraoka; Shu Kiyotoki; Mitsuhiro Fujishiro; Kazuhiko Koike
Journal:  World J Gastrointest Endosc       Date:  2016-12-16

7.  Acute Lower Gastrointestinal Bleeding: Characteristics and Clinical Outcome of Patients Treated With an Intensive Protocol.

Authors:  Georgia Diamantopoulou; Christos Konstantakis; Anastasia Kottorοu; Georgios Skroubis; Georgios Theocharis; Vasileios Theopistos; Christos Triantos; Vasiliki Nikolopoulou; Konstantinos Thomopoulos
Journal:  Gastroenterology Res       Date:  2018-01-03

8.  Patients' comorbidities reduce the clinical value of emergency colonoscopy: results of a retrospective cohort study.

Authors:  Cristiano Cremone; Anouk Esch; Charlotte Gagniere; Alessandro Fugazza; Faria Mesli; Michael Levy; Aurelien Amiot; Alexis Laurent; Yann LeBaleur; Francois Hemery; Nicolas De'Angelis; Francesco Brunetti; Iradj Sobhani
Journal:  Endosc Int Open       Date:  2017-11-08

9.  Trends in hospitalization, mortality, and timing of colonoscopy in patients with acute lower gastrointestinal bleeding.

Authors:  Kalpit Devani; Dhruvil Radadiya; Paris Charilaou; Tyler Aasen; Chakradhar M Reddy; Mark Young; Bhaumik Brahmbhatt; Don C Rockey
Journal:  Endosc Int Open       Date:  2021-05-27

10.  Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding.

Authors:  Naoyoshi Nagata; Toshiyuki Sakurai; Shiori Moriyasu; Takuro Shimbo; Hidetaka Okubo; Kazuhiro Watanabe; Chizu Yokoi; Mikio Yanase; Junichi Akiyama; Naomi Uemura
Journal:  PLoS One       Date:  2017-09-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.